Evidence map›Paper›PMID 31222620›Full record

ArticleJournal of community health2019

A Community-Based Intervention for the Detection of Chagas Disease in Barcelona, Spain.

Jordi Gómez I Prat, Paula Peremiquel-Trillas, Isabel Claveria Guiu, Estefa Choque, Inés Oliveira Souto, Núria Serre Delcor, Elena Sulleiro, Mateu Espasa, Conxita Pastoret, Juan José de Los Santos and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of community health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jordi Gómez I PratDrassanes-Vall d'Hebron International Health Unit, International Health Programme, PROSICS, Institut Català de la Salut, Av. de les Drassanes, 17, 08001, Barcelona, Catalonia, Spain. j.gomez@vhebron.net.
Paula Peremiquel-TrillasDrassanes-Vall d'Hebron International Health Unit, International Health Programme, PROSICS, Institut Català de la Salut, Av. de les Drassanes, 17, 08001, Barcelona, Catalonia, Spain.
Isabel Claveria GuiuDrassanes-Vall d'Hebron International Health Unit, International Health Programme, PROSICS, Institut Català de la Salut, Av. de les Drassanes, 17, 08001, Barcelona, Catalonia, Spain.
Estefa ChoqueDrassanes-Vall d'Hebron International Health Unit, International Health Programme, PROSICS, Institut Català de la Salut, Av. de les Drassanes, 17, 08001, Barcelona, Catalonia, Spain.
Inés Oliveira SoutoDrassanes-Vall d'Hebron International Health Unit, International Health Programme, PROSICS, Institut Català de la Salut, Av. de les Drassanes, 17, 08001, Barcelona, Catalonia, Spain.
Núria Serre DelcorDrassanes-Vall d'Hebron International Health Unit, International Health Programme, PROSICS, Institut Català de la Salut, Av. de les Drassanes, 17, 08001, Barcelona, Catalonia, Spain.
Elena SulleiroMicrobiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Mateu EspasaMicrobiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Conxita PastoretBanc de Sang i Teixits de Catalunya, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain.
Juan José de Los SantosFundación MundoSano España, Madrid, Spain.
Hakima OuaarabDrassanes-Vall d'Hebron International Health Unit, International Health Programme, PROSICS, Institut Català de la Salut, Av. de les Drassanes, 17, 08001, Barcelona, Catalonia, Spain.
Pedro Albajar ViñasControl of Neglected Tropical Diseases, Innovative & Intensified Disease Management, HIV/AIDS, Tuberculosis, Malaria and Neglected Diseases, World Health Organization, Geneva, Switzerland.
Carlos Ascaso TerrenDepartment of Public Health, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Chagas disease (CHD) has become a challenge in Spain due to the high prevalence of immigrants coming from endemic areas. One of the main difficulties for its control and elimination is its underdiagnosis. The identification and integral treatment of CHD are key to increasing rates of diagnosis, overcoming psycho-social barriers and avoiding CHD progression. Community interventions with in situ screening have proven to be a useful tool in detecting CHD among those with difficulties accessing health services. To determine the underdiagnosis rate of the population most susceptible to CHD among those attending two different Bolivian cultural events celebrated in Barcelona; to describe the sociodemographic characteristics of the people screened; and to analyse the results of the screening. The community interventions were carried out at two Bolivian cultural events held in Barcelona in 2017. Participants were recruited through community health agents. A questionnaire was given to determine the participants' prior knowledge of CHD. In situ screening was offered to those who had not previously been screened. Those who did not wish to be screened were asked for the reason behind their decision. Results were gathered in a database and statistical analyses were performed using STATA v14. 635 interviews were carried out. 95% of the subjects reported prior knowledge of CHD. 271 subjects were screened: 71.2% women and 28.8% men, of whom 87.8% were of Bolivian origin. The prevalence of CHD was 8.9%. Community health interventions with in situ screening are essential to facilitating access to diagnosis.

Indexed as

Chagas DiseaseBoliviaCommunity Health ServicesEmigrants and ImmigrantsFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMass ScreeningPrevalenceSpainChagasCommunity healthCommunity interventionsIn situ screening

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.